Compare TBI & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TBI | CDXS |
|---|---|---|
| Founded | 1985 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.9M | 141.8M |
| IPO Year | 1995 | 2008 |
| Metric | TBI | CDXS |
|---|---|---|
| Price | $3.31 | $1.58 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 254.5K | ★ 3.5M |
| Earning Date | 05-04-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.39 | 43.82 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $138,590,000.00 |
| Revenue This Year | $6.25 | $6.35 |
| Revenue Next Year | $3.90 | $16.62 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 32.30 |
| 52 Week Low | $3.42 | $0.96 |
| 52 Week High | $7.78 | $3.87 |
| Indicator | TBI | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 30.38 | 56.64 |
| Support Level | N/A | $1.57 |
| Resistance Level | $5.56 | $1.86 |
| Average True Range (ATR) | 0.23 | 0.19 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 1.32 | 42.60 |
TrueBlue Inc is a provider of specialized workforce solutions that connect employers with talent. Its reportable segments include PeopleReady, which provides blue-collar contingent staffing and delivers on-demand and skilled labor across industries such as construction, transportation, retail, hospitality, and energy. The PeopleManagement segment offers contingent labor and outsourced industrial workforce solutions, mainly on-site at client facilities, through its OnSite and Centerline operations, focusing on workforce management and commercial driver services. PeopleSolutions delivers services focused on professional and specialized talent acquisition, as well as workforce management and compliance. The company generates the majority of its revenue from the PeopleReady segment.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.